Inhibition of strigolactone receptors by N-phenylanthranilic acid derivatives: structural and functional insights C Hamiaux, RSM Drummond, Z Luo, HW Lee, P Sharma, BJ Janssen, ... Journal of Biological Chemistry 293 (17), 6530-6543, 2018 | 45 | 2018 |
A BCMAxCD3 bispecific T cell–engaging antibody demonstrates robust antitumor efficacy similar to that of anti-BCMA CAR T cells DJ DiLillo, K Olson, K Mohrs, TC Meagher, K Bray, O Sineshchekova, ... Blood advances 5 (5), 1291-1304, 2021 | 37 | 2021 |
Flexibility of the petunia strigolactone receptor DAD2 promotes its interaction with signaling partners HW Lee, P Sharma, BJ Janssen, RSM Drummond, Z Luo, C Hamiaux, ... Journal of Biological Chemistry 295 (13), 4181-4193, 2020 | 21 | 2020 |
Characterization of 7A5: a human CD137 (4-1BB) receptor binding monoclonal antibody with differential agonist properties that promotes antitumor immunity H Kotanides, RM Sattler, MB Lebron, C Carpenito, J Shen, J Li, ... Molecular Cancer Therapeutics 19 (4), 988-998, 2020 | 15 | 2020 |
Collaborative networks enable the rapid establishment of serological assays for SARS-CoV-2 during nationwide lockdown in New Zealand R McGregor, AL Whitcombe, CR Sheen, JM Dickson, CL Day, LH Carlton, ... PeerJ 8, e9863, 2020 | 13 | 2020 |
Chemical synthesis and characterization of a new quinazolinedione competitive antagonist for strigolactone receptors with an unexpected binding mode C Hamiaux, L Larsen, HW Lee, Z Luo, P Sharma, BC Hawkins, NB Perry, ... Biochemical Journal 476 (12), 1843-1856, 2019 | 8 | 2019 |
JP Allison The future of immune checkpoint therapy., 2015, 348 P Sharma DOI: https://doi. org/10.1126/science. aaa8172. PMID: https://www. ncbi. nlm …, 0 | 7 | |
Report of visit to Hyderabad (AP) DB Boralkar, C Alvares, S Devotta, PN Sharma, G Thyagarajan Supreme Court Monitoring Committee on Hazardous Wastes, Supreme Court of …, 2004 | 5 | 2004 |
In vivo determination of wound healing and antitumor properties of HPLC eluted fractions of waterweeds (Eichhornia crassipes and Pistia stratiotes) N Ganesh, P Sharma Research Journal of Life Sciences, Bioinformatics, Pharmaceutical and …, 2018 | 4 | 2018 |
Venous thromboembolic disease in children associated with COVID-19 S Narang, K Morparia, P Sharma Blood 136, 27-28, 2020 | 1 | 2020 |
Naturally acquired functional antibody responses to group A Streptococcus differ between major strain types R McGregor, A Paterson, P Sharma, T Chen, JR Lovell, LH Carlton, ... Msphere 8 (5), e00179-23, 2023 | | 2023 |
Awareness of Sickle Cell Disease Among Adolescents and Young Adults S Narang, P Sharma, E Timpo Blood 140 (Supplement 1), 11124-11124, 2022 | | 2022 |
Understanding the protein complexes involved in the reception of the plant hormone Strigolactone P Sharma PhD Thesis-University of Auckland, 2020 | | 2020 |
Characterization of a human CD137 (4-1BB) receptor binding monoclonal antibody with differential agonist properties that promotes antitumor immunity H Kotanides, RM Sattler, M Lebron, C Carpenito, J Shen, J Li, ... JOURNAL FOR IMMUNOTHERAPY OF CANCER 7, 2019 | | 2019 |
Abstract P1-08-03: Withdrawn J Sohn, P Sharma, L Dirix, J Allison, Y Ben, R Kataria, S Ferro, ... Cancer Research 78 (4_Supplement), P1-08-03-P1-08-03, 2018 | | 2018 |
Immune Thrombocytopenia (ITP): Adult Perspective P Sharma The Indian Practitioner, 39-45, 2015 | | 2015 |
S35. Investigating the ICOS/ICOSL pathway as a target for combination therapy with anti-CTLA-4 P Sharma Journal for ImmunoTherapy of Cancer 2 (Suppl 2), I6, 2014 | | 2014 |
BEYOND IMMUNE CHECKPOINT BLOCKADE: MANIPULATION OF T CELL REGULATORY CIRCUITS IN THE TREATMENT OF MELANOMA P Sharma, J Allison INFLAMMATION RESEARCH 60, 25-26, 2011 | | 2011 |
89 INVITED New Insights in Mechanism of Action of Anti-CTLA4 J Allison, P Sharma European Journal of Cancer, S23, 2011 | | 2011 |
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome HA Al-Ahmadie, X Zang, RH Thompson, AM Serio, JA Eastham, ... LABORATORY INVESTIGATION 88, 144A-144A, 2008 | | 2008 |